SCHEMBL26323917

SCHEMBL26323917

COc1cc(C=O)cc2oc(C(=O)NN)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PGR P06401 1/20 0.40
AR P10275 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
HTT P42858 1/20 0.38
TDP1 Q9NUW8 3/20 0.38
TRIM24 O15164 1/20 0.38
HPGD P15428 1/20 0.38
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6237159 0.82 KDM4E (0.50) ALDH1A1GAAKDM4EMAPTMEN1
SCHEMBL26323911 0.82 AKR1B1 (0.47) ALDH1A1GAAKDM4EMAPTMAPK1
SCHEMBL26323655 0.81 GAA (0.43) ALDH1A1GAAKDM4EMAPTMEN1
SCHEMBL5585274 0.76 HTT (0.54) ALDH1A1GAAKDM4EMAPTMEN1
SCHEMBL19862440 0.69 MAOB (0.53) ALDH1A1GAAKDM4EMAPTMEN1
SCHEMBL5584844 0.67 MAPT (0.49) ALDH1A1GAAKDM4EMAPTMEN1
SCHEMBL31723109 0.65 CNR2 (0.50) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL4600109 0.65 KDM4E (0.54) ALDH1A1GAAKDM4EMAPTMAPK1
SCHEMBL6241919 0.65 ALDH1A1 (0.60) ALDH1A1GAAKDM4EMAPTMEN1
SCHEMBL25934175 0.65 LMNA (0.44) ALDH1A1GAAKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES RELA, NFKBIA, IKBKG ALDH1A1 1094/4885GAA 1892/4885KDM4E 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.